Law makers push COVID-19 bills to prevent price gouging, track federal funds used to discover drugs

Stat News

22 June 2020 - Amid ongoing concern that COVID-19 therapies and vaccines may be unaffordable, a bipartisan group of lawmakers introduced a pair of bills Monday that would prohibit drug makers from price gouging and also require all taxpayer-funded COVID-19 research to be recorded in a federal database.

The move comes as access to COVID-19 medical products emerges as a hot-button issue in the U.S. and elsewhere, with worries mounting over the extent to which a therapy or vaccine will be available in sufficient quantities at affordable prices. 

In February, Health and Human Services Secretary Alex Azar told Congress the Trump administration wanted to make products affordable, but could not control pricing.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder